Foster & Motley Inc Novartis Ag Transaction History

Foster & Motley Inc

$1.58 Billion
Q3 2024

A detailed history of Foster & Motley Inc transactions in Novartis Ag stock. As of the latest transaction made, Foster & Motley Inc holds 18,938 shares of NVS stock, worth $1.96 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

18,938

Previous 16,138 17.35%

Holding current value

$1.96 Million

Previous $1.72 Million 26.78%

% of portfolio

0.14%

Previous 0.12%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	BUY	$106.13 - $120.89 $297,164 - $338,492	2,800 Added 17.35%	18,938 $2.18 Million
Q2 2024 Aug 02, 2024	BUY	$92.57 - $107.37 $331,400 - $384,384	3,580 Added 28.51%	16,138 $1.72 Million
Q1 2024 Apr 18, 2024	BUY	$95.27 - $108.47 $296,289 - $337,341	3,110 Added 32.92%	12,558 $1.22 Million
Q4 2023 Feb 01, 2024	BUY	$92.27 - $101.54 $402,112 - $442,511	4,358 Added 85.62%	9,448 $954,000
Q3 2023 Oct 24, 2023	BUY	$94.73 - $105.13 $138,968 - $154,225	1,467 Added 40.49%	5,090 $518,000
Q1 2023 May 09, 2023	SELL	$80.03 - $92.81 $4,161 - $4,826	-52 Reduced 1.41%	3,623 $333,000
Q4 2022 Feb 09, 2023	BUY	$75.55 - $92.52 $33,997 - $41,634	450 Added 13.95%	3,675 $333,000
Q3 2022 Nov 04, 2022	SELL	$74.61 - $87.26 $13,429 - $15,706	-180 Reduced 5.29%	3,225 $245,000
Q1 2022 Apr 28, 2022	SELL	$80.11 - $90.62 $64,007 - $72,405	-799 Reduced 19.01%	3,405 $299,000
Q4 2021 Jan 25, 2022	SELL	$79.7 - $88.13 $211,205 - $233,544	-2,650 Reduced 38.66%	4,204 $368,000
Q3 2021 Oct 29, 2021	BUY	$81.78 - $95.14 $66,487 - $77,348	813 Added 13.46%	6,854 $561,000
Q2 2021 Jul 20, 2021	SELL	$85.24 - $94.15 $27,106 - $29,939	-318 Reduced 5.0%	6,041 $551,000
Q1 2021 Apr 26, 2021	BUY	$83.5 - $98.47 $530,976 - $626,170	6,359 New	6,359 $544,000

Others Institutions Holding NVS

# of Institutions

1,431

Shares Held

134M

Call Options Held

1.1M

Put Options Held

1.71M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $222B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Foster & Motley Inc, based on Form 13F filings with the SEC.

News

Stay updated on Foster & Motley Inc with notifications on news.

Account

Foster & Motley Inc Novartis Ag Transaction History